Canaccord Genuity Group Increases Vitalhub (TSE:VHI) Price Target to C$5.50

Vitalhub (TSE:VHIFree Report) had its target price boosted by Canaccord Genuity Group from C$5.25 to C$5.50 in a report published on Tuesday, BayStreet.CA reports. They currently have a buy rating on the stock.

A number of other analysts have also issued reports on VHI. Eight Capital boosted their target price on Vitalhub from C$5.00 to C$6.25 and gave the company a buy rating in a research report on Tuesday. Cormark boosted their price objective on Vitalhub from C$5.00 to C$5.50 in a research report on Monday, November 13th.

Check Out Our Latest Analysis on Vitalhub

Vitalhub Stock Performance

TSE:VHI opened at C$5.32 on Tuesday. The stock has a 50 day moving average price of C$4.23 and a 200 day moving average price of C$3.39. The stock has a market cap of C$232.38 million, a PE ratio of 66.50, a P/E/G ratio of 0.42 and a beta of 1.33. Vitalhub has a one year low of C$2.35 and a one year high of C$5.33.

Vitalhub (TSE:VHIGet Free Report) last issued its earnings results on Thursday, November 9th. The company reported C$0.04 EPS for the quarter, topping analysts’ consensus estimates of C$0.03 by C$0.01. The company had revenue of C$13.22 million for the quarter, compared to the consensus estimate of C$12.97 million. Vitalhub had a net margin of 6.52% and a return on equity of 4.33%. As a group, analysts predict that Vitalhub will post 0.169873 earnings per share for the current fiscal year.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

See Also

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with's FREE daily email newsletter.